Hengfeng Luo

Gansu University of Traditional Chinese Medicine

Papers

Total Citations

H-Index

About

Dr. Hengfeng Luo is a urological surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for genitourinary cancers, with a particular focus on testicular cancer management. His most impactful contribution to date is a comprehensive systematic review and meta-analysis examining the clinical efficacy and safety of robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer. This 2023 study, which has already garnered 6 citations, critically evaluated whether robotic approaches can replace standard laparoscopic procedures in this complex surgical domain. By synthesizing evidence on operative outcomes, complication rates, and oncological efficacy, Dr. Luo's work provides essential guidance for urologists navigating the transition toward robotic surgery. His research addresses a critical gap in the literature, helping to establish evidence-based protocols for robotic RPLND adoption. This meta-analysis represents a significant step in validating robotic technology for challenging urological oncology procedures, potentially improving patient recovery times and surgical precision. Dr. Luo's contributions are particularly valuable for surgeons and trainees seeking to understand the comparative benefits of robotic versus traditional laparoscopic approaches in testicular cancer treatment.